SCHEMBL4565189

SCHEMBL4565189

CCc1sc(-n2cnn(Cc3ccc(F)cc3)c2=O)c(CC)c1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SCD O00767 11/20 0.50
PPARD Q03181 7/20 0.41
PPARA Q07869 7/20 0.41
PPARG P37231 4/20 0.41
P2RY14 Q15391 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4565162 0.76 PPARA (0.43) SCDPPARDPPARAPPARG
SCHEMBL243871 0.72 SCD (0.60) SCDPPARDPPARAPPARG
SCHEMBL347133 0.68 SCD (0.70) SCDPPARDPPARAPPARG
SCHEMBL347554 0.67 SCD (1.00) SCD
SCHEMBL245124 0.67 SCD (0.76) SCD
SCHEMBL242868 0.67 SCD (0.56) SCDPPARDPPARAPPARG
SCHEMBL1909733 0.65 SCD (0.52) SCDPPARDPPARAPPARG
SCHEMBL1576766 0.65 HSD17B3 (0.51) SCDPPARDPPARAPPARG
SCHEMBL1569155 0.64 KDM5A (0.58) SCDPPARDPPARAPPARG
SCHEMBL12464377 0.64 SCD (0.82) SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054408-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL Novartis Ag (CH) 2009-05-06 EP disclosed
WO-2008127349-A2 HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL NOVARTIS AG (CH) 2008-10-23 WO disclosed